Tracking U.S. Biopharma Investment: New Resources Detail State-by-State Impact

America’s biopharmaceutical sector is delivering unprecedented economic impact across the nation. Since January 2025, companies have committed more than $582 billion to bolster U.S. research and development, expand manufacturing and create jobs in communities nationwide.From cutting-edge manufacturing facilities in the South to next-generation research hubs in the Mid-Atlantic, the life sciences industry is driving local economic growth, creating high-skill jobs and ensuring Americans have faster access to breakthrough medicines.

We Work For Health created a new set of one-pagers to highlight how these investments are transforming individual states. Check out our new national one-pager and state-specific one-pagers here:

Arizona

Maintaining this momentum will require continued support from U.S. policymakers. In the face of competitive challenges internationally, particularly from China, it is crucial to uphold an environment that protects and promotes innovation — and opposes harmful policies such as most-favored-nation drug pricing.

Learn more about how policymakers can protect U.S. life sciences innovation.

SOURCE: https://www.weworkforhealth.org/post/tracking-u-s-biopharma-investment-new-resources-detail-state-by-state-impact